Reuters logo
BRIEF-Intercept Pharma surges 133.3 percent in premarket trade
January 9, 2014 / 1:16 PM / 4 years ago

BRIEF-Intercept Pharma surges 133.3 percent in premarket trade

NEW YORK, Jan 9 (Reuters) - Intercept Pharmaceuticals Inc : * Pharma surges 133.3 percent to $168.87 in premarket trade after liver disease drug meets main goal in study

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below